Cargando…

Formulation and Evaluation of Nanocrystals of a Lipid Lowering Agent

Atorvastatin calcium, the lipid lowering agent, is taken as a model drug characterized by poor water solubility and bioavailability. In this study an attempt was made for preparation of nanocrystals using high pressure homogenization. A number of stabilizers were included as well as polymers at diff...

Descripción completa

Detalles Bibliográficos
Autor principal:	Louis, Dina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986098/ https://www.ncbi.nlm.nih.gov/pubmed/27610148

Ejemplares similares

Dissolution enhancement of albendazole through nanocrystal formulation
por: Koradia, D. Krishna, et al.
Publicado: (2012)

Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503
por: Chouchou, Adrien, et al.
Publicado: (2017)

Novel Uses for Lipid-Lowering Agents
por: May, Megan Brafford, et al.
Publicado: (2016)

Novel gramicidin formulations in cationic lipid as broad-spectrum microbicidal agents
por: Ragioto, Danielle AMT, et al.
Publicado: (2014)

3D Printing of Drug Nanocrystals for Film Formulations
por: Germini, Giorgia, et al.
Publicado: (2021)

Evaluation of the safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate-to-severe pain after bunionectomy
por: Gottlieb, Ira J, et al.
Publicado: (2018)

Garlic as a Lipid Lowering Agent—A Meta-Analysis
por: Silagy, Christopher, et al.
Publicado: (1994)

Formulation and optimization of ivermectin nanocrystals for enhanced topical delivery
por: Awad, Hoda, et al.
Publicado: (2023)

Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
por: Jang, Kyungho, et al.
Publicado: (2014)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
por: Kazemi, Moloud, et al.
Publicado: (2018)

Statins and the Brain: More than Lipid Lowering Agents?
por: Fracassi, Anna, et al.
Publicado: (2019)

Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
por: Xiong, Sha, et al.
Publicado: (2020)

Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021)

FLAVOURING AGENTS IN PHARMACEUTICAL FORMULATIONS
por: Sharma, A. V., et al.
Publicado: (1988)

Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
por: Ouranidis, Andreas, et al.
Publicado: (2020)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

Role of lipid-lowering agents in the management of diabetic retinopathy
por: Ioannidou, Estelle, et al.
Publicado: (2017)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
por: Tuomela, Annika, et al.
Publicado: (2016)

Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril
por: Ekambaram, P, et al.
Publicado: (2011)

Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity
por: Maiti, Debarati, et al.
Publicado: (2023)

Production of Itraconazole Nanocrystal-Based Polymeric Film Formulations for Immediate Drug Release
por: Karagianni, Anna, et al.
Publicado: (2020)

Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy
por: Nagai, Noriaki, et al.
Publicado: (2022)

Zinc oxide nanocrystals as a nanoantibiotic and osteoinductive agent
por: Garino, Nadia, et al.
Publicado: (2019)

Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study
por: Tao, Heqing, et al.
Publicado: (2023)

In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
por: Yang, Ruyi, et al.
Publicado: (2019)

Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel
por: Pandurangan, Dinesh Kumar, et al.
Publicado: (2016)

Successful Treatment of Xanthoma Disseminatum with Combined Lipid Lowering Agents
por: Kim, Won-Jeong, et al.
Publicado: (2012)

Discovery of 7,9-Disulfatetrahydroberberine as Novel Lipid-Lowering Agents
por: Li, Dong-Dong, et al.
Publicado: (2020)

Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients
por: Abughosh, Susan M., et al.
Publicado: (2004)

Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation
por: Liu, Yuanfen, et al.
Publicado: (2022)

Regression of asymptomatic intracranial arterial stenosis by aggressive medical management with a lipid-lowering agent
por: Kim, Bo Seok, et al.
Publicado: (2019)

Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine
por: Nair, Rahul, et al.
Publicado: (2012)

Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy
por: Kurakula, Mallesh, et al.
Publicado: (2015)

Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine
por: Xiong, Wei, et al.
Publicado: (2018)

Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability
por: Ali, Hany S M, et al.
Publicado: (2019)

Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies
por: Rahim, Haroon, et al.
Publicado: (2017)

Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
por: Mulligan, H. D., et al.
Publicado: (1991)

Diethyl sinapate-grafted cellulose nanocrystals as nature-inspired UV filters in cosmetic formulations
por: Mendoza, D.J., et al.
Publicado: (2021)

Formulation and Evaluation of Guggul Lipid Nanovesicles for Transdermal Delivery of Aceclofenac
por: Gaur, Praveen Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0v2qe6ip6f91svc3mb08i26a3b